摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

quebrachamine | 4850-21-9

中文名称
——
中文别名
——
英文名称
quebrachamine
英文别名
(+)-quebrachamine;(-)-quebrachamine;11-ethyl-5,8,9,10,11,12,13,14-octahydro-6H-7,14-diaza-7,11-methano-cycloundeca[a]indene;7-Aethyl-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano-azacycloundecino[5,4-b]indol;2,12-Didehydro-12,19-seco-aspidospermidin;Quebrachamin;(15R)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene
quebrachamine化学式
CAS
4850-21-9
化学式
C19H26N2
mdl
——
分子量
282.429
InChiKey
FDNDLNFGITWTOZ-LJQANCHMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    145-147°
  • 比旋光度:
    D20 -109 to -110° (acetone)
  • 沸点:
    433.3±30.0 °C(Predicted)
  • 密度:
    1.11±0.1 g/cm3(Predicted)
  • 保留指数:
    498.03;498.03

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    19
  • 氢给体数:
    1
  • 氢受体数:
    1

SDS

SDS:16fe8d7da3e618676ae54e4d9d663c6e
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    quebrachamine正己烷 为溶剂, 反应 1.0h, 以85%的产率得到(1S,15R,18S)-15-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraen-1-ol
    参考文献:
    名称:
    Photochemical reaction of (-)-quebrachamine. Unusual photoformation of an ibogamine-like ring system
    摘要:
    DOI:
    10.1021/jo00274a038
  • 作为产物:
    描述:
    (+)-1,2,14,15-tetradehydroaspidospermidine 在 Adam’s catalyst 氢气溶剂黄146 作用下, 反应 2.0h, 以69%的产率得到quebrachamine
    参考文献:
    名称:
    通过氨基甲硅烷氧基二烯的 [4 + 2] 环加成对 AspidospermaAlkaloids 的有效方法:(±)-Tabersonine 的立体控制全合成。(+)-Tabersonine 和 (+)-16-Methoxytabersonine 的克级催化不对称合成。(+)-Aspidospermidine 和 (-)-Quebrachamine 的不对称合成
    摘要:
    描述了一种简洁、高度立体控制的吲哚生物碱 Aspidosperma 家族的策略,该策略很容易适应这些化合物的不对称合成。该策略由 (+/-)-tabersonine (rac-1) 的全合成证明,通过 12 步序列进行。这种方法的基础是我们实验室开发的 2-乙基丙烯醛与 1-氨基-3-甲硅烷氧基二烯的高度区域和立体选择性 [4 + 2] 环加成。随后通过闭环烯烃复分解反应有效地将初始加合物加工成六氢喹啉 DE 环系统。开发了烯醇甲硅烷基醚与(邻硝基苯基)苯基碘氟化物的新型邻硝基苯基化,以实现必要的吲哚部分的有效区域选择性引入。ABDE四环最终高产转化为五环目标rac-1依赖于分子内吲哚烷基化和区域选择性C-碳甲氧基化。我们的方法在战略上与以前的路线不同,并且包含访问 Aspidosperma 吲哚生物碱家族的许多其他成员所必需的内置灵活性。通过以下 Aspidosperma 生物碱的不对称
    DOI:
    10.1021/ja017863s
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL HISTONE METHYLTRANSFERASE INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS D'HISTONE MÉTHYLTRANSFÉRASES
    申请人:UNIV FREIBURG ALBERT LUDWIGS
    公开号:WO2021053158A1
    公开(公告)日:2021-03-25
    The present invention relates to novel compounds of formula (I) as defined herein. The compounds are inhibitors of histone methyltransferases of the seven-beta-strand family, in particular of KMT9.
    本发明涉及式(I)定义的新的化合物。这些化合物是七-β-链家族组蛋白甲基转移酶的抑制剂,特别是KMT9的抑制剂。
  • Divergent Asymmetric Total Synthesis of (+)-Vincadifformine, (−)-Quebrachamine, (+)-Aspidospermidine, (−)-Aspidospermine, (−)-Pyrifolidine, and Related Natural Products
    作者:Nengzhong Wang、Shuo Du、Dong Li、Xuefeng Jiang
    DOI:10.1021/acs.orglett.7b01292
    日期:2017.6.16
    uniformly strategic total synthesis of Aspidosperma alkaloids (+)-vincadifformine, ()-quebrachamine, (+)-aspidospermidine, ()-aspidospermine, ()-pyrifolidine, and nine others from efficiently constructed tricyclic ketone 13 is reported. Highlights of these divergent and practical syntheses include (i) stereoselective intermolecular [4 + 2] cycloaddition to establish a C–E ring with one all-carbon quaternary
    据报道,从有效构建的三环酮13中均匀地战略合成了曲霉属生物碱(+)-长春藤碱,(-)-quebrachamine,(+)-aspidospermidine,(-)-aspidospermine,(-)-pyrifolidine和其他9种化合物。这些不同而实用的合成方法的重点包括:(i)立体选择性分子间[4 + 2]环加成反应,以建立具有一个全碳四元立体中心(C-5)和两个桥接的连续顺式-立体中心(C-12和C-19),(ii)Pd / C催化的氢化/脱保护/酰胺化级联过程以组装D环,以及(iii)Fischer吲哚化以锻造A–B环。
  • Enantioselective Synthesis of 3,3-Disubstituted Piperidine Derivatives by Enolate Dialkylation of Phenylglycinol-Derived Oxazolopiperidone Lactams
    作者:Mercedes Amat、Oscar Lozano、Carmen Escolano、Elies Molins、Joan Bosch
    DOI:10.1021/jo070397q
    日期:2007.6.1
    dialkylation of simple phenylglycinol-derived oxazolopiperidone lactams is studied. High stereoselectivities in the generation of the quaternary stereocenter are obtained by the appropriate choice of both the configuration of the starting lactam and the order of introduction of the substituents. The usefulness of the methodology is illustrated by the conversion of some of the dialkylated lactams into known synthetic
    研究了简单的苯基甘醇衍生的恶唑并哌啶酮内酰胺的烯醇二烷基化的立体化学结果。在季立体中心的产生高的立体选择性是由内酰胺开始的两个配置和引进的取代基的数量级的适当选择而获得。通过将一些二烷基化内酰胺转化为已知的生物碱合成前体以及通过全合成(-)-quebrachamine可以说明该方法的实用性。
  • CATALYSTS FOR METATHESIS REACTIONS INCLUDING ENANTIOSELECTIVE OLEFIN METATHESIS, AND RELATED METHODS
    申请人:Malcolmson Steven J.
    公开号:US20110065915A1
    公开(公告)日:2011-03-17
    The present invention provides compositions comprising metal complexes, and related methods. In some embodiments, metal complexes of the invention may be useful as catalysts for chemical reactions, including metathesis reactions, wherein the catalysts exhibit enhanced activity and stereoselectivity. In some embodiments, the invention may advantageously provide metal complexes comprising a stereogenic metal atom. Such metal complexes may be useful in enantioselective catalysis.
    本发明提供了包括金属配合物的组合物以及相关方法。在某些实施例中,本发明的金属配合物可能作为化学反应的催化剂而有用,包括交换反应,其中催化剂表现出增强的活性和立体选择性。在某些实施例中,本发明可能有利地提供包括具有立体异性金属原子的金属配合物。这种金属配合物可能在对映选择性催化中有用。
  • Enantioselective route to both (+)- and (–)-enantiomers of quebrachamine using a single chiral synthon
    作者:Seiichi Takano、Masahiro Yonaga、Kunio Ogasawara
    DOI:10.1039/c39810001153
    日期:——
    An enantioselective route to both the (+)- and ()-enantiomers of the Aspidosperma-type indole alkalloid, quebrachamine, has been established using a single chiral lactone obtained from L-glutamic acid or D-mannitol.
    使用从L-谷氨酸或D-甘露糖醇中获得的单一手性内酯已经建立了对蛇床子型吲哚碱类(quebrachamine)的(+)-(-)和(-)-对映体的对映选择性途径。
查看更多

同类化合物

(1aR,13S,13aS)-13-乙基-1a,4,5,10,11,12,13,13a-八氢-2H-3,13-甲桥环氧乙烷并[9,10]氮杂环十一碳五烯并[5,4-b]吲哚 (-)-dehydroquebrachamine (-)-N-methylquebrachamine tetradehydro-(+)-quebrachamine (+)-14,15-didehydroquebrachamine quebrachamine 5,6,11,12-tetrahydro-4H,13aH-3a,13-propanofuro[3',2':8,9]azonino[5,4-b]indol-2(3H)-one oxoquebrachamine (+)-N-methylquebrachamine (+/-)-vincadine Vincaminoreine vincadine quebrachamine (+/-)-epivincadine 14,15,16,17-Dehydroquebrachamin (15S)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene (15R)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene 15-Ethyl-11-aza-1-azoniapentacyclo[13.3.1.01,13.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene 15-ethyl-11-aza-1-azoniapentacyclo[13.3.1.01,13.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene;magnesium(1+) monohydride;hydroxide 5,10-Dioxo-quebrachamin 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene methyl N-[(15-ethyl-2-oxo-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-ylidene)amino]carbamate 15-Ethyl-11,18-dimethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraene 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-16,17-diol 15-Ethyl-11-methyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-13-ol (1aR,13S,13aS)-13-Ethyl-1a,4,5,10,11,12,13,13a-octahydro-10-methyl-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indole 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-13-ol 15-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraen-19-ol 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-17-ol 17-Ethoxy-19-oxa-5,15-diazapentacyclo[13.6.1.01,18.04,12.06,11]docosa-4(12),6,8,10-tetraene Ervayunine 15-Ethyl-11-methyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-16,17-diol 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-2-ol 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-19-one Vincadin 15-Ethyl-13-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-19-one (±)-N-methylquebrachamine quebrachamine Methyl 17-ethyl-19-oxa-3,13-diazapentacyclo[15.2.1.02,10.04,9.013,18]icosa-2(10),4,6,8,15-pentaene-1-carboxylate 15-Ethyl-11-(methoxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene 9-Methoxy-quebrachamin dl-Vincaminorein Methyl 15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate Methyl 15-ethyl-8-methoxy-11-methyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5(10),6,8-tetraene-13-carboxylate 13-Ethyl-9-methoxy-1a,4,5,10,11,12,13,13a-octahydro-2h-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indole 15-Ethyl-8-hydroxy-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5(10),6,8-tetraen-2-one